Pharmaceuticals

Ischemic Heart Disease (IHD) Drugs Market Size, Share & Trends Analysis Report, By Disease class (angina pectoris, myocardial infarction), By Drug Class (Anti-dyslipidemic drugs, calcium channel blockers, beta-blockers, ACE inhibitors, arbs, vasodilators, antithrombotic agents), By Region, Forecasts, 2024-2031

Ischemic Heart Disease (IHD) Drugs Market Size was valued at USD 6.07 Bn in 2023 and is predicted to reach USD 8.46 Bn by 2031 at a 4.4% CAGR during the forecast period for 2024-2031. Ischemic heart disease (IHD) drugs are those that treat situations where the heart does not receive enough blood, most often because the coronary arteries are too small or too clogged. Some of these medications can alleviate chest pain, lower cholesterol, reduce ...

Report ID: 2506  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Pediatric MRI Market Size, Share & Trends Analysis Report By Type (Functional Brain MRI, Cardiac MRI, 4D MRI, and Others), Product Type (Equipment, Coil Design), Age Group, Application, and End User, Region And Segment Forecasts, 2023-2031

The Global Pediatric MRI Market Size is valued at USD 3.57 billion in 2022 and is predicted to reach USD 6.62 billion by the year 2031 at a 7.3% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: There is growing awareness among healthcare professionals and parents about the importance of early diagnosis and intervention in pediatric diseases. MRI is extensively used in pediatr...

Report ID: 2043  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use, By Region, And By Segment Forecasts, 2024-2031

The Latent Tuberculosis Infection Detection Market Size is valued at USD 1.53 billion in 2023 and is predicted to reach USD 2.37 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Latent tuberculosis infection (LTBI) detection is a critical component of tuberculosis (TB) control, aiming to prevent the progression to active TB disease. Regular screening and effective detection strategies are vital for reducing TB ...

Report ID: 2579  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 175

Allogeneic Stem Cell Transplantation Market Size, Share & Trends Analysis Report By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others), By Application (Cancer, Autoimmune Diseases, Blood Disorders, Cardiac Disorders, Neurological Disorders, Diabetes, and Others), By End User (Hospitals, Research Institutes, Specialty Clinics, and Others), By Cell Type, By Region, And By Segment Forecasts, 2023-2031.

Allogeneic Stem Cell Transplantation Market Size is valued at USD 3.66 Bn in 2022 and is predicted to reach USD 6.75 Bn by the year 2031 at a 7.21% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: The market is propelled by increased incidence of chronic illnesses such cancer, autoimmune diseases, and blood disorders. Over the past ten years, there has been a consistent rise in the number of...

Report ID: 2241  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 179

Colony Stimulating Factors Market Size, Share & Trends Analysis Report By Type, By Application, By Drug, By Dosage, By Route of administration, By Distribution Channel, By End-User, By Region, And By Segment Forecasts, 2024-2031

The Colony Stimulating Factors Market is expected to grow at a 7.90% CAGR during the forecast period for 2024-2031.  Colony stimulating factors (CSFs) are proteins that resemble hormones and encourage the development of immune cells that can fight infections. Human bodies manufacture CSFs from various cells, which can travel throughout the body and attach to cells with specific CSF receptors. CSFs can stimulate the synthesis of immune cel...

Report ID: 1382  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 190

PARP Inhibitor Biomarkers Market Size, Share & Trends Analysis Report By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others), By Region, And By Segment Forecasts, 2024-2031.

PARP Inhibitor Biomarkers Market Size is valued at USD 897.8 Mn in 2023 and is predicted to reach USD 1,751.6 Mn by the year 2031 at a 8.8% CAGR during the forecast period for 2024-2031. These biomarkers play a critical role in informing treatment decisions and identifying patients who are at the highest risk of benefiting from PARP inhibitor therapy. In order to detect these markers, genomic profiling or specific genetic assays are frequently...

Report ID: 2447  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 178

Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Panty Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others), By Region, And Segment Forecasts, 2023-2031

The Global Organic Feminine Care Market Size is valued at 2.43 billion in 2022 and is predicted to reach 3.87 billion by the year 2031 at a 5.57% CAGR during the forecast period for 2023-2031. Menstrual pads, tampons, and natural cotton pants liners are among the organic feminine care items, sometimes known as women's or cotton cleanliness items. Due to the natural cotton content, these feminine care products are disposable and biodegradable. ...

Report ID: 1734  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Molecular Beam Epitaxy Market Size, Share & Trends Analysis Report By Application (Semiconductor Devices, Optoelectronic Devices, Solar Cells), By Product (Normal MBE, Laser MBE), By Region, And By Segment Forecasts, 2024-2031.

Molecular Beam Epitaxy Market Size is valued at USD 97.6 million in 2023 and is predicted to reach USD 188.2 million by the year 2031 at an 8.7% CAGR during the forecast period for 2024-2031. Molecular beam epitaxy (MBE) allows for the precise and controlled deposition of tiny portions of numerous substances at anatomical levels on a supporting material. For the creation of superior crystallized films, it is extensively used in nanomaterials r...

Report ID: 2768  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology (MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based (Stereotactic) Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Region, And By Segment Forecasts, 2024-2031.

Breast Cancer Core Needle Biopsy Market Size is valued at USD 697.3 Mn in 2023 and is predicted to reach USD 1,042.3 Mn by the year 2031 at a 5.34% CAGR during the forecast period for 2024-2031. A biopsy is a confirmatory procedure that helps in early cancer/tumour diagnosis, resulting in faster recovery, higher survival rates, and lower rates of morbidity and mortality. A Breast Cancer Core Needle Biopsy is a less invasive alternative to surg...

Report ID: 2310  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 179

Vegetable Capsules Market Size, Share & Trends Analysis Report By Type (HPMC,Plant Polysaccharides, Starch), By Application (Pharmaceuticals, Health Supplements, Others), By Region, And By Segment Forecasts, 2024-2031.

Vegetable Capsules Market Size is valued at USD 1.45 Bn in 2023 and is predicted to reach USD 3.03 Bn by the year 2031 at a 9.7% CAGR during the forecast period for 2024-2031. Vegetable capsules serve as substitutes for conventional gelatin capsules and are often composed of hydroxypropyl methylcellulose (HPMC), which is obtained from cellulose or other plant sources such as pullulan. They are highly sought after in the pharmaceutical and nutr...

Report ID: 2465  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180